Lamivudine triphosphate TEA

Overview

Lamivudine triphosphate (3TCTP) TEA is a phosphorylated Lamivudine ( HY-B0250 ) (a nucleoside analogue). Lamivudine triphosphate TEA inhibits the reverse transcriptase of HIV or HBV viruses to block viral replication by chain termination. Lamivudine triphosphate TEA is also an inhibitor of the RdRp activity of the NS5B subunit of the HCV . Lamivudine triphosphate TEA can be incorporated into the nascent RNA by the SARS-CoV-2 RdRp, thus halting mutations in the nascent SARS-CoV-2 RNA.

Application

Products | Products > Disease Areas > Viral Infection | Products > Disease Areas > Infection | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Others | Products > Research Areas > Infection | Products > Signaling Pathways > Reverse Transcriptase | Products > Signaling Pathways > HCV | Products > Signaling Pathways > HBV | Products > Signaling Pathways > SARS-CoV | Products > Signaling Pathways > Drug Derivative

Product Information

• Catalog No.: HY-131603B
• CAS No.: 2736455-56-2
• Molecular Formula: C26H59N6O12P3S
• Molecular Weight: 772.77
• Purity: 99.89%
• Storage: -20°C, sealed storage, away from moisture and light * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
• Availability: In-stock

Source

Original product source